Possible risk of skin reaction with DPP-4 inhibitors

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-41640-x
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 5
相关论文
共 50 条
  • [41] Exploration of the DPP-4 inhibitors with a focus on saxagliptin
    Shubrook, Jay H.
    Colucci, Randall A.
    Schwartz, Frank L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2927 - 2934
  • [43] DPP-4 inhibitors and angioedema: a cause for concern?
    Byrd, Jennifer S.
    Minor, Deborah S.
    Elsayed, Raghda
    Marshall, Gallen D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 106 (05) : 436 - 438
  • [44] THE ROLE OF DPP-4 INHIBITORS IN ANGIOGENESIS IN DIABETES
    Chan, Jenq-Shyong
    Wu, Tao-Cheng
    Chen, Jaw-Wen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 171 - 172
  • [45] DPP-4 inhibitors and inflammatory bowel disease
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 359 - 359
  • [46] Novel DPP-4 inhibitors against diabetes
    Liu, Yang
    Hu, Yongzhou
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (07) : 793 - 808
  • [47] Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors
    Wu, Mei-Zhen
    Chandramouli, Chanchal
    Wong, Pui-Fai
    Chan, Yap -Hang
    Li, Hang -Long
    Yu, Si-Yeung
    Tse, Yi-Kei
    Ren, Qing-Wen
    Yu, Shuk-Yin
    Tse, Hung-Fat
    Lam, Carolyn S. P.
    Yiu, Kai-Hang
    DIABETES & METABOLISM, 2022, 48 (06)
  • [49] Plasma DPP-4 Inhibition by Sitagliptin and Other DPP-4 Inhibitors Correlates with and Predicts Glucose Lowering Efficacy
    Roy, Ranabir Sinha
    Wu, Joseph
    Eiermann, George
    Lyons, Kathryn
    He, Huaibing
    Weber, Ann
    Thornberry, Nancy
    DIABETES, 2009, 58 : A612 - A612